Your position:m.limatoxi.com >> EN >> EN >> Formulation >> Ribo Biologics announced that the worlds first FIH application for a siRNA drug targeting FXI has been successfully approved by HREC in Australia >> article
 
Ribo Biologics announced that the worlds first FIH application for a siRNA drug targeting FXI has been successfully approved by HREC in Australia
Editor:xuezhe     Clicks:0    Date:2023-2-10 15:17:32
Keyword: Ribo Biologics
Healthoo Information:
Ribo Biologics announced that the worlds first FIH application for a siRNA drug targeting FXI has been successfully approved by HREC in Australia
 
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
  Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Relative Information
  • D-Ribose reference price
  • New Tuoyang Bios first production line of isotretinoin C sodium D- rib...
  • D-Ribose reference price
  • D-Ribose reference price
  • Riboflavin sodium phosphate reference price
  • D-Ribose reference price
  • D-Ribose reference price
  • Guangji to resume Vitamin B2 production
  • D-Ribose reference price
  • Guangji and Hegno increased Riboflavin prices
  • Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463
    Baidu
    map